Palifosfamide Tromethamine

N/A

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NamePalifosfamide Tromethamine
Drug Alias Name帕磷酰胺Palifosfamide异磷酰胺氮芥PalifosfamidumZymafos +[10] 
ClassificationSmall molecules
Mechanisms of ActionAlkylating agentsDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaPanama +[23] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDekk-Tec Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndiana University School Of MedicineAlaunos Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[14] 

Other Information

ATC CodeN/A
Related LinksKEGG